ATR and cancer: Among the 290 somatic variants identified in the cancer gene consensus (CGC) cohort, the most altered genes in nonresponders were somatic variants in TP53, PIK3CA, and MUC16, whereas responders presented mutations in genes such as ATR, MAP2K1, and FAT3 (Fig. 1D).